Jane Papadaki Markley
A highly experienced commercial leader spanning business development and strategic sales and marketing, with a record of success drafting and executing highly effective sales and marketing initiatives to drive the successful launch of new technologies through superior branding and image building, addressing the preferences of Clinical Laboratories, Biotech/Pharma clients and simultaneously forging links, with strategic business partners. Regarded as an authority for consultation on Companion Dx and Personalised Medicine projects.
​
-
Recognized and recruited for ability to establish corporate commercial focus enhancing efficiency and profitability through leading cross functional teams and building strong commercial departments for development and launch of new products and services in infectious disease, molecular oncology and genomics.
​
-
An intuitive and strategic executive with proven ability to accurately measure the pulse and direction of emerging technologies and strategic alignment with the needs of the customer, working in partnership with pharma, medical societies and patient advocacy.
​
-
A proven history of successfully pioneering new technologies including instruments and assays for emerging pathogens, new biomarkers and genomic applications. Practiced in surmounting barriers to market entry, creating new markets and setting new standards for clinical diagnosis and advancing break through applications in single cell sequencing.
​